Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James L. Keck
University of Massachusetts Amherst, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Replisoma, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This outside activity with Replisoma, Inc., has a nexus with Professor Keck's research activities and is an FCOI related to the PHS funded project because the outside activity arises from and relies upon the academic expertise that qualifies this individual to participate in this PHS funded research activity.
Structure and function of the bacterial primosome
DNA replication restart is an important process to study from a human health perspective because knowing more about DNA replication will help to identify targets to kill selectively the deleterious, malignant or disease causing cells that may plague our bodies (e.g., tumors or pathogenic organisms). Conversely, this knowledge may also be used to augment the basic health and longevity of our cells. This may be translated into a longer, healthier life for the individual.
Filed on February 14, 2013.
Tell us what you know about James L. Keck's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James L. Keck filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James Keck | University of Wisconsin Madison | Conflict of Interest | Replisoma, Inc | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.